[Hepatocellular carcinoma - long-term treatable disease]
- PMID: 22920170
[Hepatocellular carcinoma - long-term treatable disease]
Abstract
Case report - 30 months surviving patient with unresectable hepatocellular carcinoma treated with sorafenib.
Similar articles
-
Target therapy for hepatocellular carcinoma: is sorafenib for everybody?J Clin Gastroenterol. 2009 May-Jun;43(5):389-90. doi: 10.1097/MCG.0b013e31819eb9a6. J Clin Gastroenterol. 2009. PMID: 19564813 No abstract available.
-
Sorafenib-induced destructive thyroiditis.Thyroid. 2010 Sep;20(9):1043-4. doi: 10.1089/thy.2010.0070. Thyroid. 2010. PMID: 20825302 No abstract available.
-
Sorafenib in advanced hepatocellular carcinoma.N Engl J Med. 2008 Dec 4;359(23):2497-8; author reply 2498-9. doi: 10.1056/NEJMc081780. N Engl J Med. 2008. PMID: 19052134 No abstract available.
-
Sorafenib in hepatocellular carcinoma.Br J Hosp Med (Lond). 2010 Aug;71(8):451-6. doi: 10.12968/hmed.2010.71.8.77669. Br J Hosp Med (Lond). 2010. PMID: 20852487 Review.
-
[Hepatocellular carcinoma].Nihon Rinsho. 2010 Oct;68(10):1861-5. Nihon Rinsho. 2010. PMID: 20954330 Review. Japanese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical